189 related articles for article (PubMed ID: 26961771)
1. Long-term results of hypofractionated stereotactic radiotherapy with CyberKnife for growth hormone-secreting pituitary adenoma: evaluation by the Cortina consensus.
Iwata H; Sato K; Nomura R; Tabei Y; Suzuki I; Yokota N; Inoue M; Ohta S; Yamada S; Shibamoto Y
J Neurooncol; 2016 Jun; 128(2):267-75. PubMed ID: 26961771
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma: high local control with low toxicity.
Iwata H; Sato K; Tatewaki K; Yokota N; Inoue M; Baba Y; Shibamoto Y
Neuro Oncol; 2011 Aug; 13(8):916-22. PubMed ID: 21665918
[TBL] [Abstract][Full Text] [Related]
3. The Clinical Outcome of Hypofractionated Stereotactic Radiotherapy With CyberKnife Robotic Radiosurgery for Perioptic Pituitary Adenoma.
Puataweepong P; Dhanachai M; Hansasuta A; Dangprasert S; Swangsilpa T; Sitathanee C; Jiarpinitnun C; Vitoonpanich P; Yongvithisatid P
Technol Cancer Res Treat; 2016 Dec; 15(6):NP10-NP15. PubMed ID: 26424501
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic conformal radiotherapy in patients with growth hormone-secreting pituitary adenoma.
Milker-Zabel S; Zabel A; Huber P; Schlegel W; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1088-96. PubMed ID: 15234043
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of fractionated stereotactic radiotherapy as third-line treatment in acromegaly.
Diallo AM; Colin P; Litre CF; Diallo MM; Decoudier B; Bertoin F; Higel B; Patey M; Rousseaux P; Delemer B
Endocrine; 2015 Dec; 50(3):741-8. PubMed ID: 25956280
[TBL] [Abstract][Full Text] [Related]
6. Long-term Outcome After Fractionated Radiotherapy for Pituitary Adenoma: The Curse of the Secretory Tumor.
Scheick S; Amdur RJ; Kirwan JM; Morris CG; Mendenhall WM; Roper S; Friedman W
Am J Clin Oncol; 2016 Feb; 39(1):49-54. PubMed ID: 25007040
[TBL] [Abstract][Full Text] [Related]
7. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas.
Minniti G; Traish D; Ashley S; Gonsalves A; Brada M
Clin Endocrinol (Oxf); 2006 May; 64(5):542-8. PubMed ID: 16649974
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiation therapy for the treatment of functional pituitary adenomas associated with feline acromegaly.
Wormhoudt TL; Boss MK; Lunn K; Griffin L; Leary D; Dowers K; Rao S; LaRue SM
J Vet Intern Med; 2018 Jul; 32(4):1383-1391. PubMed ID: 29782043
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated Radiotherapy for Pituitary Somatotroph Adenomas.
Lian X; Shen J; Gu Z; Yan J; Sun S; Hou X; You H; Xing B; Zhu H; Shen J; Zhang F
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32930785
[TBL] [Abstract][Full Text] [Related]
10. Single and hypofractionated stereotactic radiotherapy with CyberKnife for craniopharyngioma.
Iwata H; Tatewaki K; Inoue M; Yokota N; Baba Y; Nomura R; Shibamoto Y; Sato K
J Neurooncol; 2012 Feb; 106(3):571-7. PubMed ID: 21861196
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report.
Grant RA; Whicker M; Lleva R; Knisely JP; Inzucchi SE; Chiang VL
World Neurosurg; 2014; 82(1-2):195-201. PubMed ID: 23385448
[TBL] [Abstract][Full Text] [Related]
12. Acromegaly: a single centre's experience of stereotactic radiosurgery and radiotherapy for growth hormone secreting pituitary tumours with the linear accelerator.
Wilson PJ; De-Loyde KJ; Williams JR; Smee RI
J Clin Neurosci; 2013 Nov; 20(11):1506-13. PubMed ID: 23911106
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of perioptic tumors treated with hypofractionated stereotactic radiotherapy using CyberKnife® stereotactic radiosurgery.
Puataweepong P; Dhanachai M; Hansasuta A; Dangprasert S; Sitathanee C; Ruangkanchanasetr R; Yongvithisatid P
J Neurooncol; 2018 Sep; 139(3):679-688. PubMed ID: 29846895
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of patients with surgical intractable acromegaly after linear accelerator radiosurgery.
Yan JL; Chang CN; Chuang CC; Hsu PW; Lin JD; Wei KC; Lee ST; Tseng JK; Pai PC; Chen YL
J Formos Med Assoc; 2013 Jul; 112(7):416-20. PubMed ID: 23927981
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution.
Kong DS; Lee JI; Lim DH; Kim KW; Shin HJ; Nam DH; Park K; Kim JH
Cancer; 2007 Aug; 110(4):854-60. PubMed ID: 17599761
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone-secreting macroadenoma of the pituitary gland successfully treated with the radiolabeled somatostatin analog (90)Y-DOTATATE: case report.
Waligórska-Stachura J; Gut P; Sawicka-Gutaj N; Liebert W; Gryczyńska M; Baszko-Błaszyk D; Blanco-Gangoo AR; Ruchała M
J Neurosurg; 2016 Aug; 125(2):346-9. PubMed ID: 26636388
[TBL] [Abstract][Full Text] [Related]
17. Silent corticotroph adenomas after stereotactic radiosurgery: a case-control study.
Xu Z; Ellis S; Lee CC; Starke RM; Schlesinger D; Lee Vance M; Lopes MB; Sheehan J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):903-10. PubMed ID: 25216855
[TBL] [Abstract][Full Text] [Related]
18. Long-term Outcomes of Hypofractionated Stereotactic Radiotherapy for the Treatment of Perioptic Nonfunctioning Pituitary Adenomas.
Hata A; Oda M; Ono T; Suzuki A; Hanyu N; Takahashi M; Sasajima T; Hashimoto M; Nakase T; Shimizu H
Neurol Med Chir (Tokyo); 2021 Jul; 61(7):404-413. PubMed ID: 33994449
[TBL] [Abstract][Full Text] [Related]
19. The role of stereotactic radiosurgery in the multimodal management of growth hormone-secreting pituitary adenomas.
Stapleton CJ; Liu CY; Weiss MH
Neurosurg Focus; 2010 Oct; 29(4):E11. PubMed ID: 20887121
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
